SV2009003391A - Nuevos compuestos heterociclicos nitrogenados, su preparacion y su utilizacion como medicamentos antibacterianos ref. 26480sv novx54 mg - Google Patents
Nuevos compuestos heterociclicos nitrogenados, su preparacion y su utilizacion como medicamentos antibacterianos ref. 26480sv novx54 mgInfo
- Publication number
- SV2009003391A SV2009003391A SV2009003391A SV2009003391A SV2009003391A SV 2009003391 A SV2009003391 A SV 2009003391A SV 2009003391 A SV2009003391 A SV 2009003391A SV 2009003391 A SV2009003391 A SV 2009003391A SV 2009003391 A SV2009003391 A SV 2009003391A
- Authority
- SV
- El Salvador
- Prior art keywords
- preparation
- nitrogen
- novx54
- ref
- compounds
- Prior art date
Links
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 title abstract 7
- 229910052757 nitrogen Inorganic materials 0.000 title abstract 4
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 230000000844 anti-bacterial effect Effects 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- YZCKVEUIGOORGS-UHFFFAOYSA-N Hydrogen atom Chemical group [H] YZCKVEUIGOORGS-UHFFFAOYSA-N 0.000 abstract 1
- -1 NITROGEN HETEROCYCLIC COMPOUNDS Chemical class 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 229940124350 antibacterial drug Drugs 0.000 abstract 1
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 1
- 239000011707 mineral Substances 0.000 abstract 1
- 150000007530 organic bases Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/529—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
LA INVENCIÓN TRATA DE COMPUESTOS HETEROCÍCLICOS NITROGENADOS, SU PREPARACIÓN Y SU UTILIZACIÓN COMO MEDICAMENTOS ANTIBACTERIANOS, LOS COMPUESTOS DE FÓRMULA GENERAL (1): (VER FORMULA); EN LA CUAL RI REPRESENTA UN RADICAL (CH2)N-NH2 O (CH2)N-NHR, SIENDO R UN ALQUILO (C1-C6) Y SIENDO N IGUAL A 1 Ó 2; R2 REPRESENTA UN ÁTOMO DE HIDRÓGENO; R3 Y R4 FORMAN JUNTOS UN HETEROCICLO NITROGENADO DE CARÁCTER AROMÁTICO EN 5 VÉRTICES QUE COMPRENDEN 1, 2 Ó 3 ÁTOMOS DE NITRÓGENO EVENTUALMENTE SUSTITUIDOS POR UNO O VARIOS GRUPOS R', SIENDO R' ESCOGIDO ENTRE EL GRUPO FORMADO POR UN ÁTOMO DE HIDRÓGENO Y RADICALES ALQUILO QUE COMPRENDEN DE 1 A 6 ÁTOMOS DE CARBONO, EN FORMA LIBRE, DE ZWITTERIONES, Y EN FORMA DE SALES CON BASES Y ÁCIDOS MINERALES U ORGÁNICOS FARMACÉUTICAMENTE ACEPTABLES
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0702663A FR2914923B1 (fr) | 2007-04-12 | 2007-04-12 | Nouveaux composes heterocycliques azotes,leur preparation et leur utilisation comme medicaments antibacteriens. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SV2009003391A true SV2009003391A (es) | 2010-07-02 |
Family
ID=38704839
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SV2009003391A SV2009003391A (es) | 2007-04-12 | 2009-10-12 | Nuevos compuestos heterociclicos nitrogenados, su preparacion y su utilizacion como medicamentos antibacterianos ref. 26480sv novx54 mg |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US8063219B2 (es) |
| EP (1) | EP2146994B1 (es) |
| JP (1) | JP2010523630A (es) |
| KR (1) | KR20090130126A (es) |
| CN (1) | CN101687870B (es) |
| AR (1) | AR066023A1 (es) |
| AU (1) | AU2008252799B2 (es) |
| BR (1) | BRPI0809593A2 (es) |
| CA (1) | CA2683350A1 (es) |
| CL (1) | CL2008001048A1 (es) |
| CO (1) | CO6220973A2 (es) |
| CR (1) | CR11057A (es) |
| CU (1) | CU23854B1 (es) |
| EC (1) | ECSP099682A (es) |
| FR (1) | FR2914923B1 (es) |
| GT (1) | GT200900266A (es) |
| HN (1) | HN2009002099A (es) |
| IL (1) | IL201252A (es) |
| MX (1) | MX2009010837A (es) |
| MY (1) | MY152839A (es) |
| NI (1) | NI200900181A (es) |
| NZ (1) | NZ580238A (es) |
| PA (1) | PA8776401A1 (es) |
| PE (1) | PE20090235A1 (es) |
| RU (1) | RU2465276C2 (es) |
| SV (1) | SV2009003391A (es) |
| TW (1) | TWI403323B (es) |
| UY (1) | UY31016A1 (es) |
| WO (1) | WO2008142285A1 (es) |
| ZA (1) | ZA200906784B (es) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002092592A1 (de) * | 2001-05-10 | 2002-11-21 | Solvay Pharmaceuticals Gmbh | Neue 1-amidomethylcarbonyl-piperidinderivate, verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| FR2936798B1 (fr) * | 2008-10-03 | 2012-09-28 | Novexel | Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens. |
| FR2937034B1 (fr) * | 2008-10-10 | 2012-11-23 | Novexel | Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens |
| US8796257B2 (en) | 2011-12-02 | 2014-08-05 | Naeja Pharmaceutical Inc. | Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors |
| US9505761B2 (en) | 2011-12-02 | 2016-11-29 | Fedora Pharmaceuticals Inc. | Bicyclic compounds and their use as antibacterial agents and beta-lactamase inhibitors |
| AR090539A1 (es) | 2012-04-02 | 2014-11-19 | Astrazeneca Ab | COMPUESTOS INHIBIDORES DE b LACTAMASA |
| UA111925C2 (uk) | 2012-12-11 | 2016-06-24 | Федора Фармасьютікалз Інк. | БІЦИКЛІЧНІ СПОЛУКИ ТА ЇХ ВИКОРИСТАННЯ ЯК АНТИБАКТЕРІАЛЬНИХ АГЕНТІВ ТА ІНГІБІТОРІВ β-ЛАКТАМАЗИ |
| US9968593B2 (en) | 2014-11-17 | 2018-05-15 | Entasis Therapeutics Limited | Combination therapy for treatment of resistant bacterial infections |
| SMT202200397T1 (it) | 2016-09-16 | 2022-11-18 | Entasis Therapeutics Ltd | Composti inibitori di beta-lattamasi |
| PT3630111T (pt) | 2017-05-08 | 2022-03-01 | Entasis Therapeutics Inc | Compostos e métodos de tratamento de infeções bacterianas |
| WO2022047603A1 (en) | 2020-09-01 | 2022-03-10 | Ningxia Academy Of Agriculture And Forestry Sciences | Beta-lactamase inhibitors and their preparation |
| EP4146651A4 (en) | 2021-05-07 | 2024-06-05 | Ningxia Academy of Agriculture and Forestry Sciences | SULFONYLAMIDINE SUBSTITUTED COMPOUNDS AND THEIR USE AS BETA-LACTAMASE INHIBITORS |
| WO2025031214A1 (zh) * | 2023-08-08 | 2025-02-13 | 成都四面体药物研究有限公司 | 一种含脲三环的β-内酰胺酶抑制剂、其制备方法及其用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2812635B1 (fr) * | 2000-08-01 | 2002-10-11 | Aventis Pharma Sa | Nouveaux composes heterocycliques, preparation et utilisation comme medicaments notamment comme anti- bacteriens |
| FR2825705B1 (fr) * | 2001-06-08 | 2005-05-20 | Aventis Pharma Sa | Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens |
| US7439253B2 (en) * | 2002-12-06 | 2008-10-21 | Novexel | Heterocyclic compounds, their preparation and their use as medicaments, in particular as antibacterials and beta-lactamase inhibitors |
| FR2848210B1 (fr) * | 2002-12-06 | 2007-10-19 | Aventis Pharma Sa | Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens et inhibiteurs de beta-lactamases |
| RU2228934C1 (ru) * | 2003-05-20 | 2004-05-20 | ООО "Исследовательский институт химического разнообразия" | Замещенные 3,7-диазобицикло[3.3.1]нонаны, фокусированная библиотека и комбинаторная библиотека |
-
2007
- 2007-04-12 FR FR0702663A patent/FR2914923B1/fr not_active Expired - Fee Related
-
2008
- 2008-04-03 TW TW097112162A patent/TWI403323B/zh not_active IP Right Cessation
- 2008-04-03 PE PE2008000604A patent/PE20090235A1/es not_active Application Discontinuation
- 2008-04-10 UY UY31016A patent/UY31016A1/es not_active Application Discontinuation
- 2008-04-10 AR ARP080101496A patent/AR066023A1/es unknown
- 2008-04-11 MY MYPI20094278 patent/MY152839A/en unknown
- 2008-04-11 WO PCT/FR2008/000509 patent/WO2008142285A1/fr not_active Ceased
- 2008-04-11 BR BRPI0809593-0A patent/BRPI0809593A2/pt not_active IP Right Cessation
- 2008-04-11 MX MX2009010837A patent/MX2009010837A/es active IP Right Grant
- 2008-04-11 PA PA20088776401A patent/PA8776401A1/es unknown
- 2008-04-11 CA CA002683350A patent/CA2683350A1/fr not_active Abandoned
- 2008-04-11 JP JP2010502548A patent/JP2010523630A/ja active Pending
- 2008-04-11 AU AU2008252799A patent/AU2008252799B2/en not_active Ceased
- 2008-04-11 KR KR1020097023655A patent/KR20090130126A/ko not_active Ceased
- 2008-04-11 RU RU2009137255/04A patent/RU2465276C2/ru not_active IP Right Cessation
- 2008-04-11 EP EP08787944.1A patent/EP2146994B1/fr not_active Not-in-force
- 2008-04-11 CN CN2008800178276A patent/CN101687870B/zh not_active Expired - Fee Related
- 2008-04-11 US US12/595,120 patent/US8063219B2/en not_active Expired - Fee Related
- 2008-04-11 NZ NZ580238A patent/NZ580238A/en not_active IP Right Cessation
- 2008-04-11 CL CL200801048A patent/CL2008001048A1/es unknown
-
2009
- 2009-09-30 IL IL201252A patent/IL201252A/en not_active IP Right Cessation
- 2009-09-30 ZA ZA2009/06784A patent/ZA200906784B/en unknown
- 2009-10-07 EC EC2009009682A patent/ECSP099682A/es unknown
- 2009-10-09 HN HN2009002099A patent/HN2009002099A/es unknown
- 2009-10-09 NI NI200900181A patent/NI200900181A/es unknown
- 2009-10-09 GT GT200900266A patent/GT200900266A/es unknown
- 2009-10-09 CO CO09112458A patent/CO6220973A2/es not_active Application Discontinuation
- 2009-10-09 CR CR11057A patent/CR11057A/es unknown
- 2009-10-09 CU CU2009000173A patent/CU23854B1/es active IP Right Grant
- 2009-10-12 SV SV2009003391A patent/SV2009003391A/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SV2009003391A (es) | Nuevos compuestos heterociclicos nitrogenados, su preparacion y su utilizacion como medicamentos antibacterianos ref. 26480sv novx54 mg | |
| ECSP11010946A (es) | Nuevos compuestos heterocíclicos nitrogenados, preparación de los mismos y utilización de los mismos como medicamentos antibacterianos | |
| PA8845401A1 (es) | Nuevas combinaciones de compuestos heterocíclicos nitrogenados antibacterianos con otros compuestos antibacterianos ..... | |
| MX347860B (es) | Lípidos y composiciones novedosos para el suministro de agentes terapéuticos. | |
| UY31940A (es) | Derivados sustituido del 4,5-(sustituido-piridin-3-il)-1-metil-1h-indol, sus sales farmacéuticamente aceptables, polimorfos, rotámeros, pro-fármacos, anantiómeros, hidratos, solvatos del mismo, composiciones conteniéndolos y aplicaciones | |
| PA8795301A1 (es) | Derivados de 1,2,4,5-tetrahidro-3h-benzazepinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen | |
| ECSP077402A (es) | Derivados de 2-amido-4-feniltiazol, su preparación y su aplicación en terapéutica | |
| AR088226A1 (es) | Derivados piperidinicos heterociclicos, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de enfermedades neurodegenerativas | |
| AR063602A1 (es) | Derivados de espiroindolinona, formulaciones farmaceuticas que los contienen y su uso en la obtencion de un medicamento para el tratamiento de trastornos oncologicos. | |
| AR078278A1 (es) | Antagonistas de la tiazol y oxazol hepcidina, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de anemias y enfermedades asociadas a deficiencias de hierro. | |
| HN2009000502A (es) | DERIVADOS DE 2- ARIL-6-FENIL-IMIDAZO[ 1,2-a] PIRIDINAS SU PREPARACION Y SU APLICACION EN TERAPEUTICA | |
| UY31906A (es) | Derivados de n-cicloalquil-3-fenilnicotinamida que inhiben pgds, sus composiciones, su uso para el tratamiento por ejemplo de afecciones alérgicas y respiratorias. | |
| UY28823A1 (es) | Compuestos de ácido alfa aril o heteroaril metil beta piperidino propanoico como antagonistas del receptor orl1 | |
| AR067770A1 (es) | Derivados de tiazol y ditiazol para el tratamiento de diabetes | |
| UY30300A1 (es) | Compuestos triarílicos y sus derivados | |
| SV2010003779A (es) | Inhibidores de ciclopropil-polimerasa ref. tipo193 pct/slv/fd/1vh | |
| UY31712A1 (es) | Nuevos derivados de diosmetina, su procedimiento de preparacion y las composiciones farmacéuticas que los contienen | |
| ECSP088194A (es) | Antagonistas de cgrp seleccionados, procedimientos para su preparación, así como su uso como medicamentos | |
| ECSP11010962A (es) | Nevos compuestos heterocíclicos nitrogenados, su preparación y su utilización como medicamentos antibacterianos | |
| GT200700084A (es) | Derivados de indanil-piperazinas, su procedimiento de preparación y las composiciones farmaceuticas que los contienen. | |
| GT200600161A (es) | Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de los trastornos psicoticos | |
| PA8825801A1 (es) | Derivados de pirrol, su preparacion y su aplicacion en terapeutica | |
| NI200700106A (es) | Derivados de 2-amido-4-feniltiazole, su preparación y su aplicación en terapéutica | |
| UY32895A (es) | Derivados acetilénicos de 5-fenilpirazolopiridina, su preparación y su aplicación terapéutica | |
| AR059295A1 (es) | Derivados de piperidina y sus usos como antagonistas de receptores de taquiquinina. composiciones farmaceuticas. |